About
RVL Pharmaceuticals develops prescription ophthalmic products and skincare solutions focused on improving ocular vitality and aesthetics, including the FDA-approved Upneeq® for acquired blepharoptosis.
Explore RVL Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.